Principles of Caring for Bipolar Patients

Bipolar Psychopharmacotherapy: Caring for the Patient

Volumn , Issue , 2006, Pages 367-387

  Akiskal, Hagop S ^a   Akiskal, Kareen K ^b,c,d  

^a UNIVERSITY OF SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c International Mood Center   (United States)

^d French Depressive and Manic Depressive Association   (France)

Author keywords

Anti manic medications; Bipolar clinics; Caring for bipolar patients; Cyclical recurrence of depression; Eclectic psychiatry; Psychiatric hospitalization; Suicide prevention

Indexed keywords

EID: 33646510268     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470017953.ch19     Document Type: Chapter

References (49)

1. Akiskal HS. Delineating irritable-choleric and hyperthymic temperaments as variants of cyclothymia. J Person Disord. 1992; 6: 326-342.
2. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J Clin Psychopharmacol. 1996; 16 Suppl. 1: 4s-14s.
3. Akiskal HS (ed.). Bipolarity: Beyond Classic Mania. The Psychiatric Clinics of North America. Philadelphia: W.B. Saunders, September, 1999.
4. Akiskal HS. Dysthymia, cyclothymia and related chronic subthreshold mood disorders, in Gelder M, Lopez-Ibor J, Andreasen N (eds). New Oxford Textbook of Psychiatry. London, Oxford University Press, 2000, pp. 736-749.
5. Akiskal HS. Demystifying borderline personality: Critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatr Scand. 2004; 110: 401-407.
6. Akiskal HS. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: The "red sign," the "rule of three" and other biographic signs of temperamental extravagance, activation and hypomania. J Affect Disord. 2005; 84: 279-290.
7. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: Treatment implications. Psychopharmacol Bull. 1987; 23: 68-73.
8. Akiskal HS and Akiskal K. Re-assessing the prevalence of bipolar disorders: Clinical significance and artistic creativity. Psychiatrie et Psychobiologie. 1988; 3: 29s-36s.
9. Akiskal K, Akiskal HS: The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolarity and human nature. J Affect Disord. 2005; 85: 231-239.
10. Akiskal HS, Azorin JF, Hantouche EG. Proposed multidimensional structure of mania: beyond the euphoric-dysphoric dichotomy. J Affect Disord. 2003a; 73: 7-18.
11. Akiskal HS, Hantouche EG, Allilaire J-F. Bipolar II with and without cyclothymic temperament: "dark" and "sunny" expressions of soft bipolarity. J Affect Disord. 2003b; 73: 49-57.
12. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry. 1977; 134: 1227-1233.
13. Akiskal HS, Bitar AH, Puzantian VR, Rosenthal TL, Walker PW. The nosological status of neurotic depression: A prospective three-to-four year examination in light of the primarysecondary and unipolar-bipolar dichotomies. Arch Gen Psychiatry. 1978; 35: 756-766.
14. Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatr Clin North Am. 1979; 2: 527-554.
15. Akiskal HS, Puzantian VR. Psychotic forms of depression and mania. Psychiatr Clin North Am. 1979; 2: 419-439.
16. Akiskal HS, Walker PW, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness: Phenomenologic, familial, and pharmacologic predictors. J Affect Disord. 1983; 5: 115-128.
17. Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in the referred children and younger siblings of manic-depressives: Mode of onset and prospective course. Arch Gen Psychiatry. 1985a; 42: 996-1003.
18. Akiskal HS, Chen SE, Davis GC, Puzantian VR, Kashgarian M, Bolinger JM. Borderline: An adjective in search of a noun. J Clin Psychiatry. 1985b; 46: 41-48.
19. Akiskal HS, Akiskal KK, Haykal R, Manning JS, Connor P. TEMPS-A: Progress towards validation of a self-rated clinical version of the temperament evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord. 2005; 85: 3-16.
20. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002; 68: 167-81.
21. Arnold L. The Price of Greatness. New York: Guilford, 1995.
22. Bauer MS, Williford WO, Dawson EE, Akiskal HS, Altshuler L, Fye C, Gelenberg A, Glick H, Kinosian B, Sajatovic M. Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. J Affect Disord. 2001; 67: 61-78.
23. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Commes M, Corbella B, Parramon G, Corominas J. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry. 2003; 60: 402-407.
24. Coryell W, Endicott J, Keller M, Andreasen N, Grove W, Hirschfeld RM, Scheftner W. Bipolar affective disorder and high achievement: A familial association. Am J Psychiatry. 1989; 146: 983-988.
25. Deltito J, Martin L, Riefkohl J, Austria B, Kissilenko A, Corless C Morse P. Do patients with borderline personality disorder belong to the bipolar spectrum? J Affect Disord. 2001; 67: 221-228.
26. Esquirol JED. Des maladies mentales. Paris: Balliere, 1983. (Translated by EK Hunt as Mental maladies: a treatise on insanity. Philadelphia: Les and Blanchard, 1845).
27. Fieve RR. The lithium clinic: A new model for the delivery of psychiatric services. Am J Psychiatry. 1975; 132: 1018-22.
28. Fuchs T: Neurobiology and psychotherapy: An emerging dialogue. Curr Opin Psychiatry 2004; 17: 479-485.
29. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 1989; 321: 1489-93.
30. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003; 290: 1467-73.
31. Graves JS. Living with mania: A study of outpatient group psychotherapy for bipolar patients. Am J Psychother. 1993; 47: 113-26.
32. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003; 64: 161-74.
33. Jamison KR, Touched with Fire: Manic Depressive Illness and the Artistic Temperament. New York, Free Press, 1996.
34. Jamison KR, Akiskal HS: Medication compliance in patients with bipolar disorders. Psychiatr Clin North Am. 1983; 6: 175-192.
35. Krober HL: [Illness perception and coping with illness of bipolar manic-depressive patients]. Fortschr Neurol Psychiatr. 1993; Aug. 61(8): 267-73.
36. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980; 13: 156-67.
37. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry. 2003; 60: 145-52.
38. Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry. 1989; 22: 34-7.
39. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord. 1994; 31: 281-94.
40. Maremmani I, Pacini M, Lubrano S, Lovrecic M, Perugi G. Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Add & Rel Clin Probl. 2003; 5: 7-98.
41. Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J, Benebarre A, Goikolea JM, Comes M, Salamero M. Cognitive function across manic or hypomanic, depressed,and euthymic states in bipolar disorder. Am J Psychiatry. 2004; 161: 262-70.
42. Muller-Oerlinghausen B, Grof P, Schou M. Lithium and suicide prevention. Br J Psychiatry. 1999; 175: 90-1.
43. Mundt C: Psychotherapy and the novel biological paradigms-how do they relate? Seishin Shinkeigaku Zasshi. 2003; 105: 171-184.
44. Okasha A, el Akabawi AS, Snyder KS, Wilson AK, Youssef I, el Dawla AS. Expressed emotion, perceived criticism, and relapse in depression: A replication in an Egyptian community. Am J Psychiatry. 1994; 151: 1001-1005.
45. Otto MW, Reilly-Harrington N, Sachs GS. Psychoeducational and cognitive-behavioral strategies in the management of bipolar disorder. J Affect Disord. 2003; 73: 171-81.
46. Perugi G, Toni C, Akiskal HS. Anxious-bipolar comorbidity: Diagnostic and treatment challenges. Psychiatr Clin North Am. 1999; 22: 565-583.
47. Reinares M, Vieta E: The burden on the family of bipolar patients. Clin Approach Bipolar Disord. 2004; 3: 17-23.
48. Schou M: Artistic productivity and lithium prophylaxis in manic-depressive illness. Br J Psychiatry. 1979; 135: 97-103.
49. Yerevanian BI, Koek RJ, Mintz J. Lithium, anticonvulsants and suicidal behaviour in bipolar disorder. J Affect Disord. 2003; 73: 223-8.